| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |